Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13/12/22 |
James McNulty
DFI | Director of Finance/CFO | 73 | 13/12/22 |
Amy M. McCord
LAW | General Counsel | - | 01/01/19 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13/12/22 |
Samuel Sears
BRD | Director/Board Member | 80 | 02/08/13 |
Ronald Osman
BRD | Director/Board Member | 78 | 23/08/23 |
Niraj Vasisht
BRD | Director/Board Member | 61 | 13/12/22 |
Michelle Yanez
BRD | Director/Board Member | 52 | 13/12/22 |
Michael Jerman
BRD | Director/Board Member | 40 | 24/05/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 172 323 545 | 71 550 692 ( 41,52 %) | 0 | 41,52 % |
Coordinate società
Inhibitor Therapeutics, Inc.
449 South 12th Street Unit 1705
33602, Tampa
+813 864 2562
http://www.inhibitortx.com![Indirizzo HedgePath Pharmaceuticals Inc](https://cdn.zonebourse.com/static/address/13988991.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+25,83% | 46,56 Mrd | |
+45,38% | 41,67 Mrd | |
+0,69% | 41,16 Mrd | |
+30,52% | 32,4 Mrd | |
+22,30% | 28,18 Mrd | |
-6,35% | 28,1 Mrd | |
+49,25% | 14,52 Mrd | |
+49,18% | 13,74 Mrd | |
+3,45% | 12,17 Mrd |